1. Home
  2. DAN vs ADPT Comparison

DAN vs ADPT Comparison

Compare DAN & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DAN
  • ADPT
  • Stock Information
  • Founded
  • DAN 1904
  • ADPT 2009
  • Country
  • DAN United States
  • ADPT United States
  • Employees
  • DAN N/A
  • ADPT N/A
  • Industry
  • DAN Auto Parts:O.E.M.
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • DAN Consumer Discretionary
  • ADPT Health Care
  • Exchange
  • DAN Nasdaq
  • ADPT Nasdaq
  • Market Cap
  • DAN 2.4B
  • ADPT 2.0B
  • IPO Year
  • DAN N/A
  • ADPT 2019
  • Fundamental
  • Price
  • DAN $19.33
  • ADPT $17.68
  • Analyst Decision
  • DAN Buy
  • ADPT Strong Buy
  • Analyst Count
  • DAN 5
  • ADPT 10
  • Target Price
  • DAN $24.00
  • ADPT $14.10
  • AVG Volume (30 Days)
  • DAN 1.9M
  • ADPT 2.0M
  • Earning Date
  • DAN 10-29-2025
  • ADPT 11-05-2025
  • Dividend Yield
  • DAN 2.12%
  • ADPT N/A
  • EPS Growth
  • DAN N/A
  • ADPT N/A
  • EPS
  • DAN N/A
  • ADPT N/A
  • Revenue
  • DAN $9,938,000,000.00
  • ADPT $205,216,000.00
  • Revenue This Year
  • DAN N/A
  • ADPT $32.63
  • Revenue Next Year
  • DAN N/A
  • ADPT $16.31
  • P/E Ratio
  • DAN $97.89
  • ADPT N/A
  • Revenue Growth
  • DAN 7.73
  • ADPT 21.60
  • 52 Week Low
  • DAN $7.58
  • ADPT $4.27
  • 52 Week High
  • DAN $21.40
  • ADPT $17.62
  • Technical
  • Relative Strength Index (RSI)
  • DAN 51.77
  • ADPT 70.98
  • Support Level
  • DAN $18.62
  • ADPT $16.29
  • Resistance Level
  • DAN $19.36
  • ADPT $17.62
  • Average True Range (ATR)
  • DAN 0.57
  • ADPT 0.76
  • MACD
  • DAN -0.04
  • ADPT 0.22
  • Stochastic Oscillator
  • DAN 63.40
  • ADPT 95.29

About DAN Dana Incorporated

Dana Inc is engaged in the designing and manufacturing of efficient propulsion and energy-management solutions that power vehicles and machines in all mobility markets across the globe. The company has four operating segments: Light Vehicles, Power Technologies, Commercial Vehicle, and Off-Highway. The Light Vehicles segment generates the majority portion of revenue by providing products to support light vehicle OEMs. Its products are designed for light trucks, SUVs, CUVs, vans, and passenger cars.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: